Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Clinical trial NCT05195294 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05195294
Sponsor: Lion TCR Pte. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Liver Cancer, Adult Liver Cell Carcinoma

Start date: 2025-03-01
Primary completion: 2026-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.